Dataset for The cost of delivering COVID-19 vaccines in Vietnam

This study is part of a multi-country research project that utilizes standardized methods to generate cost evidence on the delivery of COVID-19 (C19) vaccines in Vietnam, Bangladesh, and the Philippines in Asia, and Mozambique, Côte d’Ivoire, the Democratic Republic of Congo, and Uganda in Africa. his was a retrospective, bottom-up costing study that estimated the financial and economic costs incurred by Vietnam’s public health system to deliver C19 vaccines in 2021. Costs were estimated for the initial low-volume period from March to June 2021, as well as the high-volume period that started in July 2021 when eligibility for C19 vaccines was expanded to the general population. The study was conducted from the payer perspective, including costs incurred by the health service providers, the NIHE, and development partners, at all levels of the health system. Data was collected retrospectively in April-May 2022 from a purposively selected sample of 26 vaccination sites within six districts and two provinces (Hanoi and Dak Lak), as well as from the regional and national level Institute for Hygiene and Epidemiology and from development partners. The sample included facility-based sites as well as temporary sites. Costs were disaggregated across program activities and resource types to analyze cost drivers. Volume-weighted average unit costs were estimated through vertical aggregation, first obtaining a total delivery cost per dose for each immunization site including costs incurred at all levels, and then estimating the weighted average across sites with the bootstrap method.